216 related articles for article (PubMed ID: 22580113)
1. MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model.
te Boekhorst BC; Jensen LB; Colombo S; Varkouhi AK; Schiffelers RM; Lammers T; Storm G; Nielsen HM; Strijkers GJ; Foged C; Nicolay K
J Control Release; 2012 Aug; 161(3):772-80. PubMed ID: 22580113
[TBL] [Abstract][Full Text] [Related]
2. PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints.
Présumey J; Salzano G; Courties G; Shires M; Ponchel F; Jorgensen C; Apparailly F; De Rosa G
Eur J Pharm Biopharm; 2012 Nov; 82(3):457-64. PubMed ID: 22922428
[TBL] [Abstract][Full Text] [Related]
3. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
[TBL] [Abstract][Full Text] [Related]
4. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
[TBL] [Abstract][Full Text] [Related]
5. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo.
Frede A; Neuhaus B; Klopfleisch R; Walker C; Buer J; Müller W; Epple M; Westendorf AM
J Control Release; 2016 Jan; 222():86-96. PubMed ID: 26699423
[TBL] [Abstract][Full Text] [Related]
6. Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model.
Scheinman RI; Trivedi R; Vermillion S; Kompella UB
Nanomedicine (Lond); 2011 Dec; 6(10):1669-82. PubMed ID: 22087799
[TBL] [Abstract][Full Text] [Related]
7. Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model.
Howard KA; Paludan SR; Behlke MA; Besenbacher F; Deleuran B; Kjems J
Mol Ther; 2009 Jan; 17(1):162-8. PubMed ID: 18827803
[TBL] [Abstract][Full Text] [Related]
8. Arthritic joint-targeting small interfering RNA-encapsulated liposome: implication for treatment strategy for rheumatoid arthritis.
Komano Y; Yagi N; Onoue I; Kaneko K; Miyasaka N; Nanki T
J Pharmacol Exp Ther; 2012 Jan; 340(1):109-13. PubMed ID: 21994423
[TBL] [Abstract][Full Text] [Related]
9. The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis.
Park JS; Yang HN; Jeon SY; Woo DG; Kim MS; Park KH
Biomaterials; 2012 Nov; 33(33):8600-12. PubMed ID: 22910222
[TBL] [Abstract][Full Text] [Related]
10. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
11. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.
Kim WU; Lee WK; Ryoo JW; Kim SH; Kim J; Youn J; Min SY; Bae EY; Hwang SY; Park SH; Cho CS; Park JS; Kim HY
Arthritis Rheum; 2002 Apr; 46(4):1109-20. PubMed ID: 11953991
[TBL] [Abstract][Full Text] [Related]
12. Intra-articular Retention and Anti-arthritic Effects in Collagen-Induced Arthritis Model Mice by Injectable Small Interfering RNA Containing Hydrogel.
Kanazawa T; Tamano K; Sogabe K; Endo T; Ibaraki H; Takashima Y; Seta Y
Biol Pharm Bull; 2017; 40(11):1929-1933. PubMed ID: 29093340
[TBL] [Abstract][Full Text] [Related]
13. Silencing TNF-α in macrophages and dendritic cells for arthritis treatment.
Ye C; Bhan AK; Deshpande V; Shankar P; Manjunath N
Scand J Rheumatol; 2013; 42(4):266-9. PubMed ID: 23582054
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate.
Aldayel AM; O'Mary HL; Valdes SA; Li X; Thakkar SG; Mustafa BE; Cui Z
J Control Release; 2018 Aug; 283():280-289. PubMed ID: 29859232
[TBL] [Abstract][Full Text] [Related]
15. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
Khoury M; Escriou V; Courties G; Galy A; Yao R; Largeau C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2008 Aug; 58(8):2356-67. PubMed ID: 18668557
[TBL] [Abstract][Full Text] [Related]
16. In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.
Shi Q; Rondon-Cavanzo EP; Dalla Picola IP; Tiera MJ; Zhang X; Dai K; Benabdoune HA; Benderdour M; Fernandes JC
Int J Nanomedicine; 2018; 13():387-402. PubMed ID: 29391796
[TBL] [Abstract][Full Text] [Related]
17. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
18. TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis.
Lee SJ; Lee A; Hwang SR; Park JS; Jang J; Huh MS; Jo DG; Yoon SY; Byun Y; Kim SH; Kwon IC; Youn I; Kim K
Mol Ther; 2014 Feb; 22(2):397-408. PubMed ID: 24145554
[TBL] [Abstract][Full Text] [Related]
19. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
20. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
